Cargando…

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis

BACKGROUND: The correlation between programmed cell death-ligand 1 (PD-L1) which may affect T cell to form the immune tolerance and breast cancer (BC) still maintains to be uncovered. This meta-analysis was about to explore PD-L1 expression as well as its prognostic role in BC. METHODS: First of all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yingzi, Tian, Jiao, Qu, Chi, Tang, Zhenrong, Wang, Yu, Li, Kang, Yang, Yuan, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717727/ https://www.ncbi.nlm.nih.gov/pubmed/33285715 http://dx.doi.org/10.1097/MD.0000000000023359

Ejemplares similares

Primary tumor resection for initially staged IV breast cancer: An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival
por: Erol, Timuçin, et al.
Publicado: (2019)

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database
por: Yang, Hao, et al.
Publicado: (2020)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
por: He, Qiang, et al.
Publicado: (2021)

High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer
por: Li, Yanqing, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis
por: Yang, Yiming, et al.
Publicado: (2017)

Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer
por: Zhang, Yi, et al.
Publicado: (2020)

The value of different imaging methods in the diagnosis of breast cancer: A protocol for network meta-analysis of diagnostic test accuracy
por: Zhang, Mei, et al.
Publicado: (2021)

ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer
por: Tang, Long-Huan, et al.
Publicado: (2023)

The efficacy of gefitinib supplementation for breast cancer: A meta-analysis of randomized controlled studies
por: Ye, Jing, et al.
Publicado: (2020)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Identification of prognostic genes for early basal-like breast cancer with weighted gene co-expression network analysis
por: Yuan, Keyu, et al.
Publicado: (2022)

Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA
por: Sheng, Xianneng, et al.
Publicado: (2017)

Efficacy and safety of Kanglaite injection combined with chemotherapy for women breast cancer: A protocol for systematic review and meta-analysis of randomized clinical trials
por: Cheng, Shengli, et al.
Publicado: (2021)

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
por: Xu, Han-Xiao, et al.
Publicado: (2016)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Induced abortion and breast cancer: An updated meta-analysis
por: Deng, Yongchun, et al.
Publicado: (2018)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

The curative effects of radiotherapy-based therapies for human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis
por: Shao, Minghai, et al.
Publicado: (2017)

Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis
por: Liu, Linlin, et al.
Publicado: (2021)

Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
por: Huang, Du-Ping, et al.
Publicado: (2016)

Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers
por: He, Ke-Wen, et al.
Publicado: (2017)

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
por: Zheng, Lihua, et al.
Publicado: (2020)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2023)

Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study
por: Zhao, Chun-Hua, et al.
Publicado: (2019)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis
por: Liu, Jiamin, et al.
Publicado: (2021)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ink4snffi87c12c0lb20th4m7d